Cite
HARVARD Citation
Vassilakopoulos, T. et al. (2023). Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era. Hematological oncology. 41 (1), pp. 97-107. [Online].